Biora Therapeutics Inc.

NASDAQ: PROG · Real-Time Price · USD
0.88
-0.04 (-3.96%)
At close: May 09, 2022, 6:00 AM

Biora Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
67.23M 88.4M 54.14M 65.99M 65.28M
Short-Term Investments
n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a
Other Long-Term Assets
326K 326K 147K 146K 199K
Receivables
n/a 653K 1.92M 5.05M 13.21M
Inventory
n/a n/a n/a n/a 12.38M
Other Current Assets
7.79M 9.38M 36.92M 43.29M 10.31M
Total Current Assets
75.02M 98.43M 92.97M 114.33M 101.17M
Property-Plant & Equipment
5.32M 4.01M 4.56M 5.47M 17.38M
Goodwill & Intangibles
6.07M 6.07M n/a n/a 9.83M
Total Long-Term Assets
11.72M 10.41M 4.71M 5.62M 27.41M
Total Assets
86.74M 108.84M 97.68M 119.95M 128.58M
Account Payables
5.38M 8.71M 7.99M 14.56M 15.63M
Deferred Revenue
194K n/a 261K 443K 211K
Short-Term Debt
1.43M n/a 110K 202K 500K
Other Current Liabilities
39.72M 52.9M 94.91M 70.43M 63.73M
Total Current Liabilities
46.73M 61.61M 103.27M 85.64M 80.06M
Long-Term Debt
127.83M 126.39M 157.26M 158.77M 161.94M
Other Long-Term Liabilities
5.36M 5.81M 14.11M 15.15M 12.08M
Total Long-Term Liabilities
133.2M 132.21M 171.37M 173.92M 174.02M
Total Liabilities
179.92M 193.81M 274.65M 259.56M 254.08M
Total Debt
129.26M n/a 157.37M 158.97M 162.44M
Common Stock
148K 146K 83K 82K 63K
Retained Earnings
-802.49M -788.69M -695.81M -652.07M -573.54M
Comprehensive Income
n/a n/a n/a n/a n/a
Shareholders Equity
-93.19M -84.98M -176.97M -139.61M -125.51M
Total Investments
n/a n/a n/a n/a n/a